Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Pathways reviewed by Gavathiotis, Evripidis (9686652)
| DB_ID | Name |
|---|---|
| 9648002 | RAS processing |
| 9652169 | Signaling by MAP2K mutants |
| 9652817 | Signaling by MAPK mutants |
| 9656223 | Signaling by RAF1 mutants |
| 9726840 | SHOC2 M1731 mutant abolishes MRAS complex function |
| 6802957 | Oncogenic MAPK signaling |
| 9726842 | Gain-of-function MRAS complexes activate RAF signaling |
| 9753512 | Signaling by RAS GTPase mutants |
| 9660537 | Signaling by MRAS-complex mutants |
Details on Person Gavathiotis, Evripidis
| Class:Id | Person:9686652 |
|---|---|
| _displayName | Gavathiotis, Evripidis |
| _timestamp | 2020-05-04 20:35:57 |
| created | [InstanceEdit:9686650] Rothfels, Karen, 2020-05-04 |
| crossReference | [DatabaseIdentifier:9686648] ORCID:0000-0001-6319-8331 |
| firstname | Evripidis |
| initial | E |
| surname | Gavathiotis |
| (author) | [InstanceEdit:9686656] Gavathiotis, Evripidis, 2020-05-04 [LiteratureReference:9686649] Current Insights of BRAF Inhibitors in Cancer [LiteratureReference:9686653] New perspectives for targeting RAF kinase in human cancer [LiteratureReference:9690171] An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling [LiteratureReference:9710645] Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 |
| [Change default viewing format] | |
